Guided Therapeutics Inc (GTHP)

[GetSeriousOK]

Disappointing press release.

No mention of US clinicals. What's causing the delay?

No explanation about why SMI failed to pay the promised $500,000 last quarter.

And no explanation of what "regulatory compliance review" in China entails or even means. The bottom line is: Chinese clinicals have not started yet.

"SMI estimates that the clinical study will be completed during the second quarter of 2022 with full approval to sell in China expected by the end of 2022?" News flash: Even if they complete clinicals in Q2 2022, there's no way the CFDA will grant full approval by the end of that year. It simply doesn't happen that fast.

SMI continues to spew BS, which is no surprise. I don't blame Gene for repeating the BS that SMI dishes up. And they did pay $133,000 for "parts and advice" which is better than nothing.

What "parts," though?